Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Allen Xue | Researchclopedia

Back to researchers

Allen Xue

National University of Singapore

57

Works

6,421

Citations

20

h-index

29

i10-index

Research Topics

CAR-T cell therapy research Lipoproteins and Cardiovascular Health Biosimilars and Bioanalytical Methods

Affiliations

Linköping University2012–2012

University of Sydney2012–2012

Amgen (United States)2012–2016

Hackensack University Medical Center2017–2017

The University of Texas MD Anderson Cancer Center2023–2023

Top Works

Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial

Frederick L. Locke,Armin Ghobadi,et al.

20182,189 citations

Lymphoma Diagnosis and Treatment

Pharmaceutical Economics and Policy

Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma

Frederick L. Locke,Sattva S. Neelapu,et al.

2017608 citations

Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels

James N. Kochenderfer,Robert Somerville,et al.

2017556 citations

Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance

Erik S.G. Stroes,David Colquhoun,et al.

2014526 citations

Effect of a Monoclonal Antibody to PCSK9 on Low-Density Lipoprotein Cholesterol Levels in Statin-Intolerant Patients

David Sullivan,Anders Olsson,et al.

2012446 citations

Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma

Frederick L. Locke,John M. Rossi,et al.

2020435 citations

Reduction in Lipoprotein(a) With PCSK9 Monoclonal Antibody Evolocumab (AMG 145)

Frederick J. Raal,Robert P. Giugliano,et al.

2014358 citations

Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma

Jennifer N. Brudno,Norris Lam,et al.

2020305 citations

PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role

Frederick J. Raal,Robert P. Giugliano,et al.

2016212 citations